Stock Alert: Lucira Health Jumps 27%

By RTTNews Staff Writer   ✉   | Published:

Shares of Lucira Health, Inc. (LHDX) are gaining over 27% on Wednesday morning after the medical technology company said that its Lucira Check It Covid-19 test kit is now available on Amazon.com in the US.

LHDX is currently trading at $6.51, up $1.42 or 27.90%, on the Nasdaq.

According to the company, Lucira Check It test kit provides a PCR quality test result at home in 30 minutes or less. After testing, users can also receive a free, text based digital verified test result on their phone for work or travel. The product costs $55 and includes free standard shipping.

For comments and feedback contact: editorial@rttnews.com

Business News

Looking to Invest in the Best Biotech Stocks? Subscribe to RTT Biotech Investor.
Editors Pick
Dash Xclusive recalled all lots of weight loss and anxiety dietary supplement Imperia Elita Vitaccino Coffee for containing undeclared sibutramine and fluoxetine, the U.S. Food and Drug Administration or FDA said in a statement. The company said the presence of sibutramine and fluoxetine in product renders it an unapproved drug or supplement for which safety and efficacy has not been established. MGM Resorts International (MGM) announced Wednesday that the Nevada Gaming Control Board has approved a return to 100 percent occupancy and no social distancing on the gaming floors located inside the company's nine Las Vegas Strip properties. The properties are - Bellagio Resort & Casino,ARIA Resort... The General Court of the European Union has annulled the European Commission's tax ruling against Amazon.com's (AMZN) subsidiaries in Europe. Amazon pursues its commercial activities in Europe through two companies established in Luxembourg - Amazon Europe Holding Technologies SCS or LuxSCS, and Amazon...